COPD

Verona Pharma Eyes NDA for COPD Drug Based on Positive Phase III Data
BioSpace
Wed, 12/21/22 - 12:00 am
Verona Pharma
COPD
ensifentrine
AstraZeneca, C4XD sign exclusive $402 million global license
Pharmaphorum
Mon, 11/28/22 - 10:20 am
AstraZeneca
C4XD
drug development
COPD
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
Yahoo/Benzinga
Wed, 09/21/22 - 10:22 am
United Therapeutics
Tyvaso
COPD
clinical trials
EpiEndo begins trial of chronic obstructive pulmonary disease treatment
Clinical Trials Arena
Thu, 09/1/22 - 10:21 am
EpiEndo Pharmaceuticals
COPD
EP395
On heels of positive COPD readout, Verona to provide new public offering
Endpoints
Wed, 08/10/22 - 10:38 am
Verona Pharma
COPD
clinical trials
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026
BioSpace
Thu, 07/21/22 - 10:24 am
Novartis
asthma
COPD
Transpire Bio signs with Recipharm for inhaled medicine development
European Pharmaceutical Review
Tue, 07/19/22 - 10:38 am
Transpire Bio
Recipharm
asthma
COPD
inhaled drugs
drug development
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
Endpoints
Wed, 06/22/22 - 06:55 pm
AstraZeneca
China
COPD
drug manufacturing
Kaleido confirms layoffs, halts planned phase 2 and appears to have ended COVID-19 program
Fierce Biotech
Sun, 01/30/22 - 11:48 am
Kaleido Biosciences
layoffs
clinical trials
COPD
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
BioSpace
Mon, 11/1/21 - 11:17 pm
AstraZeneca
COPD
Covis Pharma
Respiratory
Boost for Verona Pharma after trial win with inhaled COPD drug
Pharmaforum
Tue, 02/2/21 - 10:37 am
Verona Pharma
COPD
ensifentrine
clinical trials
Approved! FDA Grants IND Clearance to Three More Candidates Today
BioSpace
Thu, 01/28/21 - 11:14 pm
FDA
IND clearance
COPD
Zofin
Organicell
COVID-19
Passage Bio
PBFT02
frontotemporal dementia
KemPharm
KP879
stimulant use disorder
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
Pharmaceutical Business Review
Thu, 09/10/20 - 10:52 am
GSK
Innovia
Trelegy Ellipta
COPD
asthma
FDA
Verona to test COPD hopeful ensifentrine in COVID-19 patients
Pharmaforum
Tue, 09/8/20 - 10:30 pm
Verona Pharma
COVID-19
COPD
ensifentrine
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
Wed, 07/29/20 - 12:41 pm
GSK
R&D
COPD
HIV
cancer
AstraZeneca COPD drug finally gets OK from FDA, inching closer to GSK leader
Endpoints
Fri, 07/24/20 - 09:25 am
AstraZeneca
COPD
FDA
Breztri Aerosphere
PT010
GSK
Trelegy
Teva launches digital asthma and COPD rescue inhaler in US
Pharmaforum
Thu, 07/16/20 - 10:38 am
Teva Pharmaceutical
digital inhaler
asthma
COPD
rescue inhaler
ProAir Digihaler
AstraZeneca touts triplet inhaler Breztri's COPD win ahead of key FDA decision
Fierce Pharma
Thu, 06/25/20 - 07:23 pm
AstraZeneca
COPD
Breztri
clinical trials
PT010 significantly reduced rate of moderate or severe COPD exacerbations in ETHOS trial
Pharmaceutical Business Review
Thu, 06/25/20 - 10:42 am
AstraZeneca
PT010
COPD
clinical trials

Pages